Ono Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of OPHLY for the last quarter is 821.95 M USD, and it's 8.84% higher compared to the previous quarter. The net income of Q2 24 is 112.98 M USD.